[Steroid and immunosuppressive therapy in primary glomerular nephropathy (glomerulonephritis) in adults. Clinical and nephrobioptic study].
D000208:Acute Disease; D000293:Adolescent; D000328:Adult; D000368:Aged; D001379:Azathioprine / Q000627:therapeutic use*; D001623:Betamethasone / Q000627:therapeutic use; D001706:Biopsy; D002908:Chronic Disease; D005500:Follow-Up Studies; D005921:Glomerulonephritis / Q000188:drug therapy*; D006417:Hematuria; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D008775:Methylprednisolone / Q000627:therapeutic use; D008875:Middle Aged; D009401:Nephrosis / Q000188:drug therapy*; D009404:Nephrotic Syndrome / Q000188:drug therapy*; D011507:Proteinuria; D013256:Steroids / Q000627:therapeutic use*
D007166:Immunosuppressive Agents; D013256:Steroids; D001623:Betamethasone; D001379:Azathioprine; D008775:Methylprednisolone
Terapia steroidea e immunosoppressiva della nefropatia glomerulare primitiva ("glomerulonefrite") dell'adulto. Studio associato clinico-nefrobioptico.